Skip to main content
Log in

FFRCT may reduce costs in evaluation of suspected CAD

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. Prospective Longitudinal Trial of FFRCT: Outcomes and Resource Impacts

  2. The study was supported by HeartFlow, Inc.

Reference

  • Hlatky MA, et al. Quality of Life and Economic Outcomes of Assessing Fractional Flow Reserve With Computed Tomography Angiography: The PLATFORM Study. Journal of the American College of Cardiology : 14 Oct 2015. Available from: URL: http://doi.org/10.1016/j.jacc.2015.09.051

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

FFRCT may reduce costs in evaluation of suspected CAD. PharmacoEcon Outcomes News 740, 19 (2015). https://doi.org/10.1007/s40274-015-2574-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-015-2574-z

Navigation